CD4 and experimental autoimmune encephalomyelitis: It was also established that its activation inhibits the differentiation of CD4+ T-cells towards the Th17 phenotypes, and decreases the expression of IL-17 in the CD4+ T-cells infiltrating the CNS in experimental autoimmune encephalomyelitis (EAE) mice models, thus presenting strong anti-inflammatory qualities [111,112,113].